Psychosis in Parkinson’s Disease
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Psychosis in Parkinson’s disease (PD) is a fairly common and vexing problem. Although it can occur at any stage of the illness, it is a particularly important issue for patients who are in the later stages of PD and have been chronically treated with anti-PD medications. The exact pathophysiology of PD-related psychosis remains a mystery. Neurochemical imbalances, sleep disturbances, and visual processing abnormalities in PD have been implicated in its pathogenesis. Treatment of psychotic symptoms should occur only after potential medical and environmental causes of delirium have been eliminated or addressed. Initial pharmacologic changes should include limiting the patient’s anti-PD medications to those that are necessary to preserve motor function. Should that fail, an atypical antipsychotic agent is presently the treatment of choice. An emerging treatment option is the use of acetylcholinesterase inhibitors. This article reviews what is known about the epidemiology, risk factors, pathophysiology, and treatment of PD-related psychosis. ( J Geriatr Psychiatry Neurol 2004; 17:127-136)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., & Spiegel, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03399-7 · Cited by 1,182
Aghajanian, G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00135-3 · Cited by 371
Bodis-Wollner, I. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90113-o · Cited by 296 · cited 1×
“Visual dopaminergic systems, even at the level of the retina, are impaired in PD patients, but no definite functional correlate of this pathology has been identified.(38) Various other abnormalities have been discovered in visual networks of PD patients, including dysfunction of visual processing and categorization.”
BackgroundLiechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00126-3 · Cited by 245
Auditory hallucinations in Parkinson's disease
Inzelberg, R., Kipervasser, S., & Korczyn, A. D. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.533 · Cited by 179
Dream phenomena induced by chronic Levodopa therapy
Sharf, B., Moskovitz, C., Lupton, M. D., & Klawans, H. L. (1978) · Journal of Neural Transmission · doi:10.1007/bf01579073 · Cited by 137 · cited 1×
“It is well recognized that dopaminergic agonists, such as cocaine and amphetamine, can induce psychotic states(22); conversely, dopamine antagonists such as haloperidol and pimozide are effective antipsychotics.(19) There are experimental suggestions that chronic stimulation may cause persistent sensitization of dopam…”
Background
Cited by
Aarsland, D., Bronnick, K., Ehrt, U., De Deyn, P. P., Tekin, S., Emre, M., & Cummings, J. L. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083113 · Cited by 521
Meltzer, H. Y., Mills, R., Revell, S., Williams, H., Johnson, A., Bahr, D., & Friedman, J. H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.176 · Cited by 292
Cognitive dysfunction and dementia in Parkinson?s disease
Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0168-1 · Cited by 273
Ehrt, U., Broich, K., Larsen, J. P., Ballard, C., & Aarsland, D. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.186239 · Cited by 254
Psychosis in Parkinson’s disease
Thanvi, B. R., Lo, T. C. N., & Harsh, D. P. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.032029 · Cited by 55
Metadata
- Authors
- Wint, D. P., Okun, M. S., & Fernandez, H. H.
- Venue
- Journal of Geriatric Psychiatry and Neurology
- Publisher
- SAGE Publications
- Published
- 2004-09
- Volume
- 17
- Issue
- 3
- Pages
- 127-136
- ISSN
- 0891-9887 (ISSN-L)
- 1552-5708
- OpenAlex
- W2104295755
- Cited by
- 57
- References
- 6
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychosis in Parkinson’s Disease. https://app.cochat.ai/papers/10.1177/0891988704267457
- The paper
- Wint, D. P., Okun, M. S., & Fernandez, H. H. (2004). Psychosis in Parkinson’s Disease. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988704267457
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.